Impact of the N-terminal domain of STAT3 in STAT3-dependent transcriptional activity

Molecular and Cellular Biology

Volumn 35, Issue 19, 2015, Pages 3284-3300

  Hu, Tiancen ^a   Yeh, Jennifer E ^b,c   Pinello, Luca ^b,e   Jacob, Jaison ^a   Chakravarthy, Srinivas ^d   Yuan, Guo Cheng ^b,e   Chopra, Rajiv ^a   Frank, David A ^b,c,d,e,f  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d ARGONNE NATIONAL LABORATORY   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DIMER; EARLY GROWTH RESPONSE FACTOR 1; KRUPPEL LIKE FACTOR 4; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; NICKEL; OLIGOMER; STAT1 PROTEIN; STAT3 PROTEIN; STAT4 PROTEIN; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR JUNB; LIF PROTEIN, MOUSE; PROTEIN BINDING; STAT3 PROTEIN, MOUSE;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIMERIZATION; DNA BINDING; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENE INDUCTION; GENE MUTATION; HYDROGEN BOND; IN VITRO STUDY; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SIZE EXCLUSION CHROMATOGRAPHY; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; GENETIC TRANSCRIPTION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; UPREGULATION; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CRYSTALLOGRAPHY, X-RAY; LEUKEMIA INHIBITORY FACTOR; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84941142868     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00060-15     Document Type: Article

References (77)

1. Stark GR, Darnell JE, Jr. 2012. The JAK-STAT pathway at twenty. Immunity 36:503-514. http://dx.doi.org/10.1016/j.immuni.2012.03.013.
2. Bromberg J. 2002. Stat proteins and oncogenesis. J Clin Invest 109:1139-1142. http://dx.doi.org/10.1172/JCI0215617.
3. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE, Jr. 1999. Stat3 as an oncogene. Cell 98:295-303. http://dx.doi.org/10.1016/S0092-8674(00)81959-5.
4. Buettner R, Mora LB, Jove R. 2002. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8:945-954.
5. Levy DE, Inghirami G. 2006. STAT3: a multifaceted oncogene. Proc Natl Acad Sci U S A 103:10151-10152. http://dx.doi.org/10.1073/pnas.0604042103.
6. Sansone P, Bromberg J. 2012. Targeting the interleukin-6/Jak/Stat pathway in human malignancies. J Clin Oncol 30:1005-1014. http://dx.doi.org/10.1200/JCO.2010.31.8907.
7. Timofeeva OA, Gaponenko V, Lockett SJ, Tarasov SG, Jiang S, Michejda CJ, Perantoni AO, Tarasova NI. 2007. Rationally designed inhibitors identify STAT3 N-domain as a promising anticancer drug target. ACS Chem Biol 2:799-809. http://dx.doi.org/10.1021/cb700186x.
8. Becker S, Groner B, Muller CW. 1998. Three-dimensional structure of the Stat3beta homodimer bound to DNA. Nature 394:145-151. http://dx.doi.org/10.1038/28101.
9. Nkansah E, Shah R, Collie GW, Parkinson GN, Palmer J, Rahman KM, Bui TT, Drake AF, Husby J, Neidle S, Zinzalla G, Thurston DE, Wilderspin AF. 2013. Observation of unphosphorylated STAT3 core protein binding to target dsDNA by PEMSA and X-ray crystallography. FEBS Lett 587:833-839. http://dx.doi.org/10.1016/j.febslet.2013.01.065.
10. Ren Z, Mao X, Mertens C, Krishnaraj R, Qin J, Mandal PK, Romanowski MJ, McMurray JS, Chen X. 2008. Crystal structure of unphosphorylated STAT3 core fragment. Biochem Biophys Res Commun 374: 1-5. http://dx.doi.org/10.1016/j.bbrc.2008.04.049.
11. Zhang X, Darnell JE, Jr. 2001. Functional importance of Stat3 tetramerization in activation of the alpha 2-macroglobulin gene. J Biol Chem 276: 33576-33581. http://dx.doi.org/10.1074/jbc. M104978200.
12. Lerner L, Henriksen MA, Zhang X, Darnell JE, Jr. 2003. STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene. Genes Dev 17:2564-2577. http://dx.doi.org/10.1101/gad.1135003.
13. Lin JX, Li P, Liu D, Jin HT, He J, Ata Ur Rasheed M, Rochman Y, Wang L, Cui K, Liu C, Kelsall BL, Ahmed R, Leonard WJ. 2012. Critical role of STAT5 transcription factor tetramerization for cytokine responses and normal immune function. Immunity 36:586-599. http://dx.doi.org/10.1016/j.immuni.2012.02.017.
14. Cimica V, Chen HC, Iyer JK, Reich NC. 2011. Dynamics of the STAT3 transcription factor: nuclear import dependent on Ran and importin-beta1. PLoS One 6:e20188. http://dx.doi.org/10.1371/journal.pone.0020188.
15. Pranada AL, Metz S, Herrmann A, Heinrich PC, Muller-Newen G. 2004. Real time analysis of STAT3 nucleocytoplasmic shuttling. J Biol Chem 279:15114-15123. http://dx.doi.org/10.1074/jbc. M312530200.
16. Vogt M, Domoszlai T, Kleshchanok D, Lehmann S, Schmitt A, Poli V, Richtering W, Muller-Newen G. 2011. The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3. J Cell Sci 124:900-909. http://dx.doi.org/10.1242/jcs.072520.
17. Timofeeva OA, Chasovskikh S, Lonskaya I, Tarasova NI, Khavrutskii L, Tarasov SG, Zhang X, Korostyshevskiy VR, Cheema A, Zhang L, Dakshanamurthy S, Brown ML, Dritschilo A. 2012. Mechanisms of unphosphorylated STAT3 transcription factor binding to DNA. J Biol Chem 287:14192-14200. http://dx.doi.org/10.1074/jbc. M111.323899.
18. Timofeeva OA, Tarasova NI, Zhang X, Chasovskikh S, Cheema AK, Wang H, Brown ML, Dritschilo A. 2013. STAT3 suppresses transcription of proapoptotic genes in cancer cells with the involvement of its N-terminal domain. Proc Natl Acad Sci U S A 110:1267-1272. http://dx.doi.org/10.1073/pnas.1211805110.
19. Zhao Y, Zeng C, Tarasova NI, Chasovskikh S, Dritschilo A, Timofeeva OA. 2013. A new role for STAT3 as a regulator of chromatin topology. Transcription 4:227-231. http://dx.doi.org/10.4161/trns.27368.
20. Domoszlai T, Martincuks A, Fahrenkamp D, Schmitz-Van de Leur H, Kuster A, Muller-Newen G. 2014. Consequences of the disease-related L78R mutation for dimerization and activity of STAT3. J Cell Sci 127: 1899-1910. http://dx.doi.org/10.1242/jcs.137422.
21. Pilati C, Amessou M, Bihl MP, Balabaud C, Nhieu JT, Paradis V, Nault JC, Izard T, Bioulac-Sage P, Couchy G, Poussin K, Zucman-Rossi J. 2011. Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J Exp Med 208:1359-1366. http://dx.doi.org/10.1084/jem.20110283.
22. Primiano T, Baig M, Maliyekkel A, Chang BD, Fellars S, Sadhu J, Axenovich SA, Holzmayer TA, Roninson IB. 2003. Identification of potential anticancer drug targets through the selection of growthinhibitory genetic suppressor elements. Cancer Cell 4:41-53. http://dx.doi.org/10.1016/S1535-6108(03)00169-7.
23. Hossain DM, Panda AK, Manna A, Mohanty S, Bhattacharjee P, Bhattacharyya S, Saha T, Chakraborty S, Kar RK, Das T, Chatterjee S, Sa G. 2013. FoxP3 acts as a cotranscription factor with STAT3 in tumor-induced regulatory T cells. Immunity 39:1057-1069. http://dx.doi.org/10.1016/j.immuni.2013.11.005.
24. Hou T, Ray S, Brasier AR. 2007. The functional role of an interleukin 6-inducible CDK9 · STAT3 complex in human gamma-fibrinogen gene expression. J Biol Chem 282:37091-37102. http://dx.doi.org/10.1074/jbc. M706458200.
25. 2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen. Gastroenterology 129:1616-1632. http://dx.doi.org/10.1053/j.gastro.2005.07.055.
26. Ray S, Lee C, Hou T, Bhakat KK, Brasier AR. 2010. Regulation of signal transducer and activator of transcription 3 enhanceosome formation by apurinic/apyrimidinic endonuclease 1 in hepatic acute phase response. Mol Endocrinol 24:391-401. http://dx.doi.org/10.1210/me.2009-0319.
27. Ray S, Lee C, Hou T, Boldogh I, Brasier AR. 2008. Requirement of histone deacetylase1 (HDAC1) in signal transducer and activator of transcription 3 (STAT3) nucleocytoplasmic distribution. Nucleic Acids Res 36:4510-4520. http://dx.doi.org/10.1093/nar/gkn419.
28. 2 terminal mono-ubiquitination promotes BRD4 complex formation to regulate apoptosis. Cell Signal 26:1445-1455. http://dx.doi.org/10.1016/j.cellsig.2014.03.007.
29. Wang WB, Levy DE, Lee CK. 2011. STAT3 negatively regulates type I IFN-mediated antiviral response. J Immunol 187:2578-2585. http://dx.doi.org/10.4049/jimmunol.1004128.
30. Ndubuisi MI, Guo GG, Fried VA, Etlinger JD, Sehgal PB. 1999. Cellular physiology of STAT3: where's the cytoplasmic monomer? J Biol Chem 274:25499-25509. http://dx.doi.org/10.1074/jbc.274.36.25499.
31. Chua AC, Klopcic BR, Ho DS, Fu SK, Forrest CH, Croft KD, Olynyk JK, Lawrance IC, Trinder D. 2013. Dietary iron enhances colonic inflammation and IL-6/IL-11-Stat3 signaling promoting colonic tumor development in mice. PLoS One 8:e78850. http://dx.doi.org/10.1371/journal.pone.0078850.
32. Novak U, Ji H, Kanagasundaram V, Simpson R, Paradiso L. 1998. STAT3 forms stable homodimers in the presence of divalent cations prior to activation. Biochem Biophys Res Commun 247:558-563. http://dx.doi.org/10.1006/bbrc.1998.8829.
33. Kitabayashi C, Fukada T, Kanamoto M, Ohashi W, Hojyo S, Atsumi T, Ueda N, Azuma I, Hirota H, Murakami M, Hirano T. 2010. Zinc suppresses Th17 development via inhibition of STAT3 activation. Int Immunol 22:375-386. http://dx.doi.org/10.1093/intimm/dxq017.
34. Ng DC, Lin BH, Lim CP, Huang G, Zhang T, Poli V, Cao X. 2006. Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin. J Cell Biol 172:245-257. http://dx.doi.org/10.1083/jcb.200503021.
35. Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, Derecka M, Szczepanek K, Szelag M, Gornicka A, Moh A, Moghaddas S, Chen Q, Bobbili S, Cichy J, Dulak J, Baker DP, Wolfman A, Stuehr D, Hassan MO, Fu XY, Avadhani N, Drake JI, Fawcett P, Lesnefsky EJ, Larner AC. 2009. Function of mitochondrial Stat3 in cellular respiration. Science 323: 793-797. http://dx.doi.org/10.1126/science.1164551.
36. Costa-Pereira AP, Tininini S, Strobl B, Alonzi T, Schlaak JF, Is'harc H, Gesualdo I, Newman SJ, Kerr IM, Poli V. 2002. Mutational switch of an IL-6 response to an interferon-gamma-like response. Proc Natl Acad Sci U S A 99:8043-8047. http://dx.doi.org/10.1073/pnas.122236099.
37. Alonzi T, Maritano D, Gorgoni B, Rizzuto G, Libert C, Poli V. 2001. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver. Mol Cell Biol 21:1621-1632. http://dx.doi.org/10.1128/MCB.21.5.1621-1632.2001.
38. Grant CE, Bailey TL, Noble WS. 2011. FIMO: scanning for occurrences of a given motif. Bioinformatics 27:1017-1018. http://dx.doi.org/10.1093/bioinformatics/btr064.
39. Nelson EA, Walker SR, Alvarez JV, Frank DA. 2004. Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification. J Biol Chem 279:54724-54730. http://dx.doi.org/10.1074/jbc. M408464200.
40. Karplus PA, Diederichs K. 2012. Linking crystallographic model and data quality. Science 336:1030-1033. http://dx.doi.org/10.1126/science.1218231.
41. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. 2007. Phaser crystallographic software. J Appl Crystallogr 40: 658-674. http://dx.doi.org/10.1107/S0021889807021206.
42. Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and devel-opment of Coot. Acta Crystallogr D Biol Crystallogr 66:486-501. http://dx.doi.org/10.1107/S0907444910007493.
43. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213-221. http://dx.doi.org/10.1107/S0907444909052925.
44. Brunger AT. 2007. Version 1.2 of the crystallography and NMR system. Nat Protoc 2:2728-2733. http://dx.doi.org/10.1038/nprot.2007.406.
45. Blanc E, Roversi P, Vonrhein C, Flensburg C, Lea SM, Bricogne G. 2004. Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT. Acta Crystallogr D Biol Crystallogr 60:2210-2221. http://dx.doi.org/10.1107/S0907444904016427.
46. Mathew E, Mirza A, Menhart N. 2004. Liquid-chromatography-coupled SAXS for accurate sizing of aggregating proteins. J Synchrotron Radiat 11(Pt 4):314-318. http://dx.doi.org/10.1107/S0909049504014086.
47. Konarev P, Petoukhov M, Volkov V, Svergun D. 2006. ATSAS 2.1, a program package for small-angle scattering data analysis. J Appl Crystallogr 39:277-286. http://dx.doi.org/10.1107/S0021889806004699.
48. Bourillot PY, Aksoy I, Schreiber V, Wianny F, Schulz H, Hummel O, Hubner N, Savatier P. 2009. Novel STAT3 target genes exert distinct roles in the inhibition of mesoderm and endoderm differentiation in cooperation with Nanog. Stem Cells 27:1760-1771. http://dx.doi.org/10.1002/stem.110.
49. Carpenter RL, Lo HW. 2014. STAT3 target genes relevant to human cancers. Cancers 6:897-925. http://dx.doi.org/10.3390/cancers6020897.
50. Snyder M, Huang XY, Zhang JJ. 2008. Identification of novel direct Stat3 target genes for control of growth and differentiation. J Biol Chem 283: 3791-3798. http://dx.doi.org/10.1074/jbc. M706976200.
51. Alvarez JV, Febbo PG, Ramaswamy S, Loda M, Richardson A, Frank DA. 2005. Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors. Cancer Res 65: 5054-5062. http://dx.doi.org/10.1158/0008-5472.CAN-04-4281.
52. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B. 2004. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32:D91-D94. http://dx.doi.org/10.1093/nar/gkh012.
53. Begitt A, Droescher M, Meyer T, Schmid CD, Baker M, Antunes F, Knobeloch KP, Owen MR, Naumann R, Decker T, Vinkemeier U. 2014. STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signaling. Nat Immunol 15:168-176. http://dx.doi.org/10.1038/ni.2794.
54. Mao X, Ren Z, Parker GN, Sondermann H, Pastorello MA, Wang W, McMurray JS, Demeler B, Darnell JE, Jr, Chen X. 2005. Structural bases of unphosphorylated STAT1 association and receptor binding. Mol Cell 17:761-771. http://dx.doi.org/10.1016/j.molcel.2005.02.021.
55. Vinkemeier U, MoarefiI, Darnell JE, Jr, Kuriyan J. 1998. Structure of the amino-terminal protein interaction domain of STAT-4. Science 279: 1048-1052. http://dx.doi.org/10.1126/science.279.5353.1048.
56. Chen X, Bhandari R, Vinkemeier U, Van Den Akker F, Darnell JE, Jr, Kuriyan J. 2003. A reinterpretation of the dimerization interface of the N-terminal domains of STATs. Protein Sci 12:361-365. http://dx.doi.org/10.1110/ps.0218903.
57. Hou Z, Srivastava S, Mistry MJ, Herbst MP, Bailey JP, Horseman ND. 2003. Two tandemly linked interferon-gamma-activated sequence elements in the promoter of glycosylation-dependent cell adhesion molecule 1 gene synergistically respond to prolactin in mouse mammary epithelial cells. Mol Endocrinol 17:1910-1920. http://dx.doi.org/10.1210/me.2003-0045.
58. Meyer T, Hendry L, Begitt A, John S, Vinkemeier U. 2004. A single residue modulates tyrosine dephosphorylation, oligomerization, and nuclear accumulation of Stat transcription factors. J Biol Chem 279:18998-19007. http://dx.doi.org/10.1074/jbc. M400766200.
59. Ota N, Brett TJ, Murphy TL, Fremont DH, Murphy KM. 2004. N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. Nat Immunol 5:208-215. http://dx.doi.org/10.1038/ni1032.
60. Mertens C, Zhong M, Krishnaraj R, Zou W, Chen X, Darnell JE, Jr. 2006. Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain. Genes Dev 20:3372-3381. http://dx.doi.org/10.1101/gad.1485406.
61. Wenta N, Strauss H, Meyer S, Vinkemeier U. 2008. Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations. Proc Natl Acad Sci U S A 105:9238-9243. http://dx.doi.org/10.1073/pnas.0802130105.
62. John S, Vinkemeier U, Soldaini E, Darnell JE, Jr, Leonard WJ. 1999. The significance of tetramerization in promoter recruitment by Stat5. Mol Cell Biol 19:1910-1918.
63. Murphy TL, Geissal ED, Farrar JD, Murphy KM. 2000. Role of the Stat4 N domain in receptor proximal tyrosine phosphorylation. Mol Cell Biol 20:7121-7131. http://dx.doi.org/10.1128/MCB.20.19.7121-7131.2000.
64. Yang J, Huang J, Dasgupta M, Sears N, Miyagi M, Wang B, Chance MR, Chen X, Du Y, Wang Y, An L, Wang Q, Lu T, Zhang X, Wang Z, Stark GR. 2010. Reversible methylation of promoter-bound STAT3 by histonemodifying enzymes. Proc Natl Acad SciUS A 107:21499-21504. http://dx.doi.org/10.1073/pnas.1016147107.
65. Zhang L, Badgwell DB, Bevers JJ, III, Schlessinger K, Murray PJ, Levy DE, Watowich SS. 2006. IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain. Mol Cell Biochem 288:179-189. http://dx.doi.org/10.1007/s11010-006-9137-3.
66. Brantley EC, Benveniste EN. 2008. Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomas. Mol Cancer Res 6:675-684. http://dx.doi.org/10.1158/1541-7786.MCR-07-2180.
67. Hussain SF, Kong LY, Jordan J, Conrad C, Madden T, Fokt I, Priebe W, Heimberger AB. 2007. A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients. Cancer Res 67:9630-9636. http://dx.doi.org/10.1158/0008-5472.CAN-07-1243.
68. Kasprzycka M, Marzec M, Liu X, Zhang Q, Wasik MA. 2006. Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3. Proc Natl Acad Sci U S A 103:9964-9969. http://dx.doi.org/10.1073/pnas.0603507103.
69. Kortylewski M, Kujawski M, Wang T, Wei S, Zhang S, Pilon-Thomas S, Niu G, Kay H, Mule J, Kerr WG, Jove R, Pardoll D, Yu H. 2005. Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity. Nat Med 11:1314-1321. http://dx.doi.org/10.1038/nm1325.
70. Yu H, Kortylewski M, Pardoll D. 2007. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat Rev Immunol 7:41-51. http://dx.doi.org/10.1038/nri1995.
71. Timofeeva OA, Tarasova NI. 2012. Alternative ways of modulating JAKSTAT pathway: looking beyond phosphorylation. JAKSTAT 1:274-284. http://dx.doi.org/10.4161/jkst.22313.
72. Droescher M, Begitt A, Marg A, Zacharias M, Vinkemeier U. 2011. Cytokine-induced paracrystals prolong the activity of signal transducers and activators of transcription (STAT) and provide a model for the regulation of protein solubility by small ubiquitin-like modifier (SUMO). J BiolChem286: 18731-18746. http://dx.doi.org/10.1074/jbc. M111.235978.
73. Herrmann A, Sommer U, Pranada AL, Giese B, Kuster A, Haan S, Becker W, Heinrich PC, Muller-Newen G. 2004. STAT3 is enriched in nuclear bodies. J Cell Sci 117:339-349. http://dx.doi.org/10.1242/jcs.00833.
74. Freitas M, Fernandes E. 2011. Zinc, cadmium and nickel increase the activation of NF-kappaB and the release of cytokines from THP-1 monocytic cells. Metallomics 3:1238-1243. http://dx.doi.org/10.1039/c1mt00050k.
75. Atsumi T, Singh R, Sabharwal L, Bando H, Meng J, Arima Y, Yamada M, Harada M, Jiang JJ, Kamimura D, Ogura H, Hirano T, Murakami M. 2014. Inflammation amplifier, a new paradigm in cancer biology. Cancer Res 74:8-14. http://dx.doi.org/10.1158/0008-5472.CAN-13-2322.
76. Bode JG, Fischer R, Haussinger D, Graeve L, Heinrich PC, Schaper F. 2001. The inhibitory effect of IL-1 beta on IL-6-induced alpha 2-macroglobulin expression is due to activation of NF-kappa B. J Immunol 167: 1469-1481. http://dx.doi.org/10.4049/jimmunol.167.3.1469.
77. Meyer WK, Reichenbach P, Schindler U, Soldaini E, Nabholz M. 1997. Interaction of STAT5 dimers on two low affinity binding sites mediates interleukin 2 (IL-2) stimulation of IL-2 receptor alpha gene transcription. J Biol Chem 272:31821-31828. http://dx.doi.org/10.1074/jbc.272.50.31821.